Title
SplitPlot Designs: FollowUp Experiments, Missing Observations, and Model Adequacy Checking,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Splitplot designs are effective in industry due to time and/or cost constraints, restriction on randomization of the treatment combinations of the hardtochange factors and different sizes of experimental units. Some of the results of fractional factorial splitplot experiments can be ambiguous and a need may arise to conduct followup experiments to separate effects of potential interest.The first objective of this research is to extend the foldover technique to break the alias chains of splitplot experiments.Six rules are provided to develop foldovers for minimum aberration resolution III and resolution IV FFSP designs.The second objective is to extend a method due to Draper and Stoneman to estimate missing observations from unreplicated twolevel factorial and FFSP designs. The missing observations, which can either be from the same wholeplot, from different WPs, or comprise entire WPs, are estimated by equating to zero a number of specific contrast columns equal to the number of the missing observations.The third objective is to develop numerical and graphical methods to check for any violation of the underlying assumptions and the adequacy of fit of splitplot models.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.